Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations by Muir Tobian, Wohlgemuth Walter A, Cemazar Maja, Bertino Giulia, Groselj Ales, Ratnam Lakshmi A, McCafferty Ian, Wildgruber Moritz, Gebauer Bernhard, de Terlizzi Francesca, Zanasi Alessandro, Sersa Gregor

Subjects: Get full text

Hepatic and immune modulatory effectiveness of lactoferrin loaded Selenium nanoparticles on bleomycin induced hepatic injury by Khaled G. Abdel-Wahhab, Mahmoud Ashry, Laila K. Hassan, Marwa H. El-Azma, Ghada M. Elqattan, Mohamed H. A. Gadelmawla, Fathia A. Mannaa

Subjects: Get full text

Inhibition of skin fibrosis via regulation of Th17/Treg imbalance in systemic sclerosis by Akiko Sekiguchi, Chikako Shimokawa, Tamotsu Kato, Akihiko Uchiyama, Yoko Yokoyama, Sachiko Ogino, Ryoko Torii, Hajime Hisaeda, Hiroshi Ohno, Sei-ichiro Motegi

Subjects: Get full text

Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis by Kangchen Li, Xuefang Liu, Ruilong Lu, Peng Zhao, Yange Tian, Jiansheng Li

Subjects: “…Bleomycin pollution…”
Get full text

FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis by Yu Cheng, Yang Jiao, Wan Wei, Mengjia Kou, Yaodong Cai, Yang Li, Hao Li, Tonghua Liu

Subjects: Get full text